Maria Mar Hernandez Guillamon Senior Researcher, Neurovascular Research Lab, VHIR. Institutions of which they are part Main researcher Neurovascular Diseases Vall Hebron Institut de Recerca Twitter Maria Mar Hernandez Guillamon Twitter Institutions of which they are part Main researcher Neurovascular Diseases Vall Hebron Institut de Recerca Senior Researcher, Neurovascular Research Lab, VHIR.
Dr. Mar Hernández-Guillamon has dedicated her career to the study of cerebral amyloid angiopathy (CAA) and other pathologies associated with the deposition of amyloid-beta (Abeta). In 2013, she was awarded by Carlos III Spanish Health Institute with the Miguel Servet contract to establish the Cerebral Amyloidosis line of research at VHIR. Her group has positioned in forefront of the Abeta-pathologies field, studying the molecular mechanisms involved in the Abeta transport and metabolism using in vitro and in vivo models. Her lab has also dedicated to the clinical research and discovery of biomarkers associated with CAA and other cerebrovascular diseases. The translational research developed by Dr. Hernandez-Guillamon's group has allowed the achievement of important aims to date, as demonstrated by the scientific production obtained (h-index= 35, 80 publications, >3700 citations) and the continuous leadership of national and international projects.
Projects Malalties Neurovasculars (GRC) IP: Joan Montaner Villalonga Collaborators: Marta Aurora Rubiera Del Fueyo, Jorge Pagola Pérez Blanca, Bustamante Rangel, Alejandro, José Alvarez Sabin, Anna Penalba Morenilla, Maria Mar Hernandez Guillamon, Yolanda Riba Llena, Marc Ribó Jacobi, Maria Pilar Delgado Martínez, Carlos Molina Cateriano, Anna Rosell Novel, David Rodriguez Luna, Mª Ángeles Muchada López, Estevo Santamarina Pérez, Manuel Quintana Luque Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 48000 Reference: 2014 SGR 686 Duration: 01/01/2014 - 31/12/2016 Marcadores radiológicos y biológicos de disfunción cerebrovascular en la Angiopatía Amiloide Cerebral IP: Maria Mar Hernandez Guillamon Collaborators: Bustamante Rangel, Alejandro, Jessica Camacho Soriano Funding agency: Instituto de Salud Carlos III Funding: 98615 Reference: PI14/01134 Duration: 01/01/2015 - 31/05/2018 Therapeutic impact of ApoJ/Clusterin-coupled liposomes on Alzheimer's disease experimental models IP: Maria Mar Hernandez Guillamon Collaborators: Elena Antima Martinez Saez Funding agency: Fundació La Marató de TV3 Funding: 200000 Reference: 20141910 Duration: 17/02/2015 - 31/01/2019 Preventing cardiovascular ischemic events and arresting their consequences in type 2 diabetic population: a multidisciplinary clinical and experimental approach IP: - Collaborators: Ignacio Ferreira González, José Antonio Barrabés Riu, Bustamante Rangel, Alejandro, Joan Montaner Villalonga, Immaculada Raurell Saborit, Joan López Hellin, Antonio González Fernández, Antonia Sambola Ayala, Marta García Ramírez, Joaquin Lopez Soriano, Anna Meseguer Navarro, Antonio Rodríguez Sinovas, Artur Evangelista Masip, Rafael Simó Canonge, Santiago Aguade Bruix, Francesc Moreso Mateos, Cristina Hernández Pascual, Anna Penalba Morenilla, Maria Nieves Martell Pérez-Alcalde, Neus Bellera Gotarda, Natalia Ramos Terrades, Andreea Ciudin Mihai, Maria Mar Hernandez Guillamon, Yolanda Riba Llena, Meritxell Ibernon Vilaró, Ignasi Barba Vert, Jordi Bañeras Rius, Bruno García del Blanco, Daniel Serón Micas, María Eugenia Espinel Garuz, Marisol Ruiz Meana, Maria Pilar Delgado Martínez, Irene Montllor Ramoneda, Irina Betsabe Torres Rodriguez, Javier Inserte Igual, Anna Rosell Novel, Olga Simó Servat, Joan Genescà Ferrer, Mònica Pons Delgado, M Antonieta Azancot Rivero, Maria Nazarena Pizzi, M Antonieta Azancot Rivero Funding agency: Instituto de Salud Carlos III Funding: 825000 Reference: PIE13/00027 Duration: 01/01/2014 - 30/06/2018 Pagination First page « Previous page ‹ … Page 3 Page 4 Current page 5 Page 6 Page 7 … Next page › Last page »
